TIGAR induces p53-mediated cell-cycle arrest by regulation of RB-E2F1 complex

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• p53 is a tumor suppressor that induces cell-cycle arrest and apoptosis, and it negatively regulates glycolysis through TIGAR.
• While TIGAR protects against reactive oxygen species and apoptosis, its role in p53's tumor-suppressor activity and glycolysis regulation remains unclear.

Purpose of the Study:

• To investigate the relationship between TIGAR-mediated glycolysis inhibition and p53's tumor-suppressor function.
• To elucidate the mechanism by which TIGAR influences cell-cycle progression and tumor regression.

Main Methods:

• Gene expression analysis using RT-PCR and Western blot.
• Assays including luciferase and chromatin immunoprecipitation to study TIGAR gene regulation.
• Co-immunoprecipitation to assess TIGAR's role in RB-E2F1 interaction and in vivo studies using MCF-7 tumor xenografts.

Main Results:

• TIGAR promotes p53-mediated G1-phase arrest independently of p21.
• p53 activates the TIGAR promoter under specific stress conditions.
• TIGAR suppresses cell-cycle gene synthesis (CDK-2, CDK-4, CDK-6, Cyclin D, Cyclin E) and promotes RB de-phosphorylation, stabilizing the RB-E2F1 complex and blocking cell cycle entry into S phase.

Conclusions:

• TIGAR inhibits cancer cell proliferation by mediating RB de-phosphorylation and stabilizing the RB-E2F1 complex, thus delaying cell cycle entry into S phase.
• TIGAR enhances drug-mediated tumor regression by promoting p53-induced cell-cycle arrest.